Goldman Myla Lai

Insider Reports History

Location
3595 John Hopkins Court, San Diego, CA
Signature
/s/ Brian Keane, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Goldman Myla Lai:

Stock Role Class Num Shares Value Price $ Report Date Ownership
WEST PHARMACEUTICAL SERVICES INC Director Common Stock 19.4K $3.91M $201.47 May 6, 2025 Direct
Quanterix Corp Director Common Stock 29.5K $163K $5.54 Oct 1, 2025 Direct
Akoya Biosciences, Inc. Director Common Stock 0 $0 $1.16 Jul 8, 2025 Direct
Quanterix Corp Director Stock Option (right to buy) 50.8K Jul 8, 2025 Direct
Akoya Biosciences, Inc. Director Stock Option (right to buy) 0 Jul 8, 2025 Direct

Insider Reports Filed by Goldman Myla Lai

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QTRX Quanterix Corp Oct 1, 2025 1 $11.5K 4 Oct 3, 2025 Director
QTRX Quanterix Corp Jul 8, 2025 3 $0 4 Jul 10, 2025 Director
AKYA Akoya Biosciences, Inc. Jul 8, 2025 5 $0 4 Jul 10, 2025 Director
QTRX Quanterix Corp Jul 8, 2025 0 $0 3 Jul 9, 2025 Director
WST WEST PHARMACEUTICAL SERVICES INC May 6, 2025 1 $0 4 May 8, 2025 Director
AKYA Akoya Biosciences, Inc. Jun 4, 2024 1 $0 4 Jun 5, 2024 Director
WST WEST PHARMACEUTICAL SERVICES INC Apr 23, 2024 1 $0 4 Apr 25, 2024 Director
AKYA Akoya Biosciences, Inc. Jun 12, 2023 1 $100K 4 Jun 12, 2023 Director
AKYA Akoya Biosciences, Inc. Jun 1, 2023 1 $0 4 Jun 5, 2023 Director
WST WEST PHARMACEUTICAL SERVICES INC Apr 25, 2023 1 $0 4 Apr 27, 2023 Director
AKYA Akoya Biosciences, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
WST WEST PHARMACEUTICAL SERVICES INC May 24, 2022 1 $0 4 May 26, 2022 Director
AKYA Akoya Biosciences, Inc. Sep 16, 2021 1 $0 4 Sep 20, 2021 Director
AKYA Akoya Biosciences, Inc. Sep 16, 2021 0 $0 3 Sep 20, 2021 Director